Loading ...

lipid nanoparticles

Based on

1 Articles
2016 Most recent source

Composition

Image only illustrates the order and placement of components as described in literature.

1

buffer solution

Type Complex Compound
Formula
Role core
2

C12-200/DOPE/cholesterol/C14-PEG mixture

Type Complex Compound
Formula
Role layer

Applications

Area Application Nanomaterial Variant Source
drug delivery

More information available to subscribers only.

Or, view sample content

Characterization

Method Nanomaterial Variant Source
dynamic light scattering

More information available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • cholesterol
  • (9Z)-9-Octadecenoic acid (1R)-1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-1,2-ethanediyl ester
  • 1,1'-((2-(4-(2-((2-(bis(2-hydroxydodecyl)amino)ethyl)(2-hydroxydodecyl)amino)ethyl)piperazin-1-yl)ethyl)azanediyl)bis(dodecan-2-ol)
See all (4)
  1. t13AoI4Cc7avz04Dtf5NuxUs5GOmXqsnjQ
  2. ZS76
  3. x5IyQ9kK2Y7J58QjdZG9g3Fs
Product

lipid nanoparticles

Hydrodynamic diameter: 41 - 105 nm

Medium: buffer solution

Support: none

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial